Navigation Links
Aratana Therapeutics Appoints Craig Tooman to Board of Directors
Date:5/9/2012

KANSAS CITY, Kan. and NEW YORK, May 9, 2012 /PRNewswire/ -- Aratana Therapeutics, an animal health company developing innovative medicines for companion animals, has announced the appointment of Craig Tooman, to its Board of Directors.

During his distinguished career, Mr. Tooman has held various senior positions in the pharmaceutical industry in international finance, sales, market research, business intelligence, strategic business management, and investor relations. After nearly a decade with Pharmacia & Upjohn (now Pfizer), Mr. Tooman moved to the biotechnology industry.

Mr. Tooman has made substantial contributions to companies including Ilex Oncology, which was sold to Genzyme Corporation for $1.1 billion; Enzon Pharmaceuticals and Ikaria.  Mr. Tooman has recently been appointed CEO of Avanzar Medical, and he has been named entrepreneur-in-residence by the Cancer Prevention and Research Institute of Texas.

"Craig's exceptional track record guiding the evolution of different types of life sciences companies, his experience not just with finance but with all the disciplines that create a company's growth potential, and his ability to communicate with the financial community are skills Aratana will draw on extensively as we continue to develop new medicines to address unmet needs in companion animal health," says Board of Directors Chair Dr. Steven St. Peter.

Mr. Tooman has a Bachelor of Arts degree in economics with a minor in Japanese Language and a concentration in International Finance from Kalamazoo College. He received his MBA in Finance from the University of Chicago.

"Aratana's business model is unique and compelling in the animal health industry, and I believe the team guiding the company is exceptional," Mr. Tooman says. "I look forward to serving on the Board of Directors and helping shape the future of this very exciting enterprise."

About Aratana Therapeutics

Aratana Therapeutics is an animal health drug development company uniquely positioned to deliver high quality new medicines for unmet needs in animal health. Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then out-licenses to or partners with major animal health companies for commercialization. For more information, please visit www.aratanatherapeutics.com.

Contact: Dr. Linda Rhodes, CEO (lrhodes@aratanarx.com), 732-895-5420


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Aratana Therapeutics Announces $20 Million Financing
2. Aratana Therapeutics Completes $15 Million Series B Financing
3. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
4. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
5. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
6. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
7. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
8. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
9. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
10. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
11. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... Lady had been battling arthritis since the age of two and at ... owner Hannah sought the help of Dr Jeff Christiansen of Superior Veterinary Surgical ... and help with the pain of Lady’s arthritis. Dr Christiansen suggested that in conjunction ...
(Date:5/24/2016)... Mass. (PRWEB) , ... May 24, 2016 , ... ... heart attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester ... cells into engines of wound healing and tissue regeneration. , The novel method, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, an integrated wealth management ... The Future of San Diego Life Science event at the Estancia La Jolla Resort ... the event with speakers Dr. Rich Heyman, former CEO of Aragon and Seragon, and ...
(Date:5/23/2016)... ... , ... The need for blood donations in South Texas and across the nation is growing. ... Tissue Center, blood donations are on the decline. In fact, donations across the country are ... in South Texas in the last four years alone. , There is no substitute for ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):